Biomarkers in Systemic Sclerosis

Biomarkers in Systemic Sclerosis - Biomarkers in SSc

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30650

Enrollment

215

Registered

2007-06-13

Start date

2007-07-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scleroderma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Written informed consent

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
To construct a biobank with peripheral blood and material from skin biopsies from patients with SSc to evaluate (new) antigens and/or (new) antibodies and to compare these between subsets of SSc, and to correlate these findings to disease characteristics like subsets of SSc (limited or diffuse cutaneous SSc, limited SSc), disease duration, presence and extend of organ involvement (skin, lung, heart, renal, gastrointestinal involvement). Studyparameters/ endpoints will be determined depending hypotheses of experiments.	—

Measure

Time frame

To construct a biobank with peripheral blood and material from skin biopsies from patients with SSc to evaluate (new) antigens and/or (new) antibodies and to compare these between subsets of SSc, and to correlate these findings to disease characteristics like subsets of SSc (limited or diffuse cutaneous SSc, limited SSc), disease duration, presence and extend of organ involvement (skin, lung, heart, renal, gastrointestinal involvement). Studyparameters/ endpoints will be determined depending hypotheses of experiments.

—

Secondary

Measure	Time frame
Secundary studyparameters/ endpoints will be determined depending hypotheses of experiments.	—

Countries

Netherlands

Outcome results